Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Ophthalmic Surgical Instruments Market worth $ 11.18 Billion by 2022

Author: Snehal Shaha
by Snehal Shaha
Posted: Nov 08, 2019

Growth in this market is attributed to the rapid growth in the geriatric population, increasing number of ophthalmic surgeries owing to the rising prevalence of eye diseases, technological advancement in ophthalmic surgical instruments, and government initiatives to increase awareness about visual impairment across the globe.

The global Ophthalmic Surgical Instruments Market is projected to reach USD 11.18 Billion by 2022 from USD 8.36 Billion in 2017, at a CAGR of 6.0%.

Based on product, the ophthalmic surgical instruments market is segmented into cataract surgery devices, vitreoretinal surgery devices, refractive surgery devices, glaucoma surgery devices, ophthalmic microscopes, and accessories. The cataract surgery devices segment accounted for the major share of the global ophthalmic surgical instruments market. The large share of this segment can primarily be attributed to the growing number of cataract surgeries across the globe. Glaucoma surgery devices segment is expected to register the highest growth during the forecast period. The high growth of this segment is attributed to the rising prevalence of glaucoma and technological advancements in the glaucoma surgical devices throughout the world.

On the basis of refractive surgery devices, the ophthalmic surgical instruments market is segmented into femtosecond lasers, excimer lasers, other lasers, and refractive surgery instruments & kits. The femtosecond lasers segment accounted for the major share of the refractive surgery devices market and is also expected to register the highest CAGR during the forecast period. The large share and high growth of this segment is attributed to its benefits such as lower incidence of dry eyes, less induced aberrations, greater safety, faster uncorrected visual acuity recovery, less intraocular pressure (IOP) variation in the femtosecond-created flap, and growing number of femtosecond laser-assisted surgeries being performed across the globe.

Vitreoretinal packs dominated the vitreoretinal surgery devices market in 2016

On the basis of vitreoretinal surgery devices type, the ophthalmic surgical instruments market is segmented into vitreoretinal packs, vitrectomy machines, photocoagulation lasers, illumination devices, vitrectomy probes, and vitreoretinal surgery instruments & kits. In 2016, the vitreoretinal packs segment accounted for the major share of the vitreoretinal surgery devices market. The advantages of vitreoretinal packs, such as it minimizes trauma to the eye and less procedural time required to perform surgeries, are driving the growth of the vitreoretinal surgery devices market.

North America dominated the market in 2016

North America accounted for the largest share of the ophthalmic surgical instruments market in 2016, followed by Europe. The large share of this region is attributed to rising prevalence of ocular disorders owing to growing geriatric population in North America, increase in healthcare expenditure, technological advancements in instruments & devices used for minimally invasive surgeries, and increasing regulatory approvals.

Read more :- https://www.marketsandmarkets.com/PressReleases/ophthalmic-surgical-instrument.asp

The prominent players in the ophthalmic surgical instruments market are Alcon (Switzerland), Carl Zeiss Meditec (Germany), Johnson & Johnson Vision Care (US), Hoya Corporation (Japan), Bausch + Lomb (US), NIDEK (Japan), Topcon Corporation (Japan), Ellex Medical Lasers (Australia), IRIDEX Corporation (US), Lumenis (Israel), STAAR Surgical Company (US), and Ziemer Ophthalmic Systems (Switzerland).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

About the Author

About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

Rate this Article
Leave a Comment
Author Thumbnail
Please or Join to add a comment.
Author: Snehal Shaha

Snehal Shaha

India

Member since: Jul 09, 2019
Published articles: 48

Related Articles